Clinical Research Directory
Browse clinical research sites, groups, and studies.
Clinical Study of HRS-2129 for Acute Gouty Arthritis
Sponsor: Shandong Suncadia Medicine Co., Ltd.
Summary
The study is being conducted to evaluate the safety, and efficacy of HRS-2129 for acute gouty arthritis. To explore the reasonable dosage of HRS-2129 for acute gouty arthritis.
Official title: Clinical Study on Safety and Efficacy of HRS-2129 for Acute Gouty Arthritis
Key Details
Gender
All
Age Range
18 Years - Any
Study Type
INTERVENTIONAL
Enrollment
90
Start Date
2026-07
Completion Date
2026-11
Last Updated
2026-07-16
Healthy Volunteers
No
Conditions
Interventions
HRS-2129 Tablet
HRS-2129 Tablet; high dose
HRS-2129 Tablet
HRS-2129 Tablet; low dose
Placebo
HRS-2129 Tablet Placebo
Locations (2)
The Third Affiliated Hospital of Sun Yat-sen University
Guangzhou, Guangdong, China
Nanjing Drum Tower Hospital, The Affiliated Hospital of Nanjing University Medical School
Nanjing, Jiangsu, China